Research progress of moyamoya disease combined with renovascular hypertension
Moyamoya disease (MMD) is an idiopathic cerebrovascular disease which was first described by Suzuki and Takaku in 1969. Moyamoya disease is a non-atherosclerotic cerebrovascular structural disorder. MMD has been found all over the world, especially in Japan, Korea, and China. In recent years, many r...
Main Authors: | Erheng Liu, Heng Zhao, Chengyuan Liu, Xueyi Tan, Chao Luo, Shuaifeng Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2022.969090/full |
Similar Items
-
Research progress on moyamoya disease combined with thyroid diseases
by: Guibo Zhang, et al.
Published: (2023-10-01) -
RNF213 R4810K Variant in Suspected Unilateral Moyamoya Disease Predicts Contralateral Progression
by: Taedong Ok, et al.
Published: (2022-08-01) -
Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review
by: Yuting Luo, et al.
Published: (2022-03-01) -
Pathophysiology and management of renovascular hypertension
by: Łukasz Dobrek
Published: (2020-09-01) -
Systemic vasculopathy associated with an RNF213 p.Arg4810Lys variant in moyamoya disease: A review
by: Duk-Kyung Kim, et al.
Published: (2022-09-01)